Related Experiment Video

Updated: Aug 30, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis

Ji Hoon Kim1, Byoung Kwon Kim, Kyung Chul Moon

  • 1Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.

Kidney International
|October 9, 2003
PubMed
Abstract

Insights

Damage to podocytes in focal segmental glomerulosclerosis (FSGS) may activate the transforming growth factor-beta (TGF-beta)/Smad signaling pathway. This activation in glomerular epithelial cells (GEC) leads to extracellular matrix overproduction, contributing to FSGS development.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pathology

Background:

  • Transforming growth factor-beta (TGF-beta) is implicated in glomerulosclerosis.
  • The specific role of TGF-beta signal transduction in focal segmental glomerulosclerosis (FSGS) and its activation mechanism remain unclear.

Purpose of the Study:

  • To investigate the involvement of the TGF-beta/Smad signaling pathway in FSGS pathogenesis.
  • To determine how TGF-beta 1 is activated during FSGS development.

Main Methods:

  • Immunohistochemistry was used to analyze TGF-beta 1, thrombospondin-1 (TSP-1), TGF-beta type II receptor (TGF-beta IIR), phosphorylated Smad2/Smad3, and podocyte markers (WT-1, GLEPP-1) in FSGS and control renal biopsies.
  • In situ hybridization assessed mRNA expression of TGF-beta 1, TGF-beta IIR, and TSP-1.

Main Results:

  • Control biopsies showed minimal expression of TGF-beta pathway components, while FSGS biopsies exhibited significantly increased protein and mRNA levels of TGF-beta 1, TSP-1, TGF-beta IIR, and phosphorylated Smad2/Smad3.
  • Elevated expression was concentrated in glomerular epithelial cells (GEC) of sclerotic segments, where podocyte markers (WT-1, GLEPP-1) were absent.

Conclusions:

  • Podocyte injury in FSGS appears to trigger TGF-beta 1, TSP-1, and TGF-beta IIR expression in GEC.
  • Activation of the TGF-beta/Smad signaling pathway in GEC promotes extracellular matrix overproduction, contributing to FSGS development.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...